CDX2: Linking Cell and Patient Fates in Colon Cancer

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Administering adjuvant chemotherapy to stage II colon cancer patients is controversial due to limited benefit observed for this subpopulation. Recently, Dalerba et al. (2016) identified a subgroup of stage II patients that might benefit from adjuvant chemotherapy based on lack of CDX2 expression in their cancer stem cells.

Cite

CITATION STYLE

APA

Fearon, E. R., & Huang, E. H. (2016, February 4). CDX2: Linking Cell and Patient Fates in Colon Cancer. Cell Stem Cell. Cell Press. https://doi.org/10.1016/j.stem.2016.01.011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free